220 related articles for article (PubMed ID: 30368777)
1. Cancer stem cells in esophageal cancer and response to therapy.
Harada K; Pool Pizzi M; Baba H; Shanbhag ND; Song S; Ajani JA
Cancer; 2018 Oct; 124(20):3962-3964. PubMed ID: 30368777
[TBL] [Abstract][Full Text] [Related]
2. Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer.
Liu K; Zhao T; Wang J; Chen Y; Zhang R; Lan X; Que J
Cancer Lett; 2019 Aug; 458():21-28. PubMed ID: 31125642
[TBL] [Abstract][Full Text] [Related]
3. Predicting the Correlation of EZH2 and Cancer Stem Cell Markers in Esophageal Squamous Cell Carcinoma.
Karami Madani G; Rad A; Molavi M; Ardalan Khales S; Abbaszadegan MR; Forghanifard MM
J Gastrointest Cancer; 2018 Dec; 49(4):437-441. PubMed ID: 28681114
[TBL] [Abstract][Full Text] [Related]
4. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
5. Understanding the cellular origin and progression of esophageal cancer using esophageal organoids.
Sachdeva UM; Shimonosono M; Flashner S; Cruz-Acuña R; Gabre JT; Nakagawa H
Cancer Lett; 2021 Jul; 509():39-52. PubMed ID: 33838281
[TBL] [Abstract][Full Text] [Related]
6. MiR-139-5p regulates VEGFR and downstream signaling pathways to inhibit the development of esophageal cancer.
Jiao W; Zhang J; Wei Y; Feng J; Ma M; Zhao H; Wang L; Jiao W
Dig Liver Dis; 2019 Jan; 51(1):149-156. PubMed ID: 30245290
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and treatment of early esophageal squamous cell carcinoma and precancerous lesions].
Xing J; Li P
Zhonghua Nei Ke Za Zhi; 2020 Apr; 59(4):318-321. PubMed ID: 32209201
[TBL] [Abstract][Full Text] [Related]
8. Detention and Identification of Cancer Stem Cells in Esophageal Squamous Cell Carcinoma.
Islam F; Gopalan V; Lam AK
Methods Mol Biol; 2020; 2129():177-191. PubMed ID: 32056178
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Exploration to Identify Predictive DNA Markers of ΔNp63/SOX2 in Drug Resistance in Human Esophageal Squamous Cell Carcinoma.
Ooizumi Y; Kojima K; Igarashi K; Tanaka Y; Harada H; Yokota K; Kaida T; Ishii S; Tanaka T; Yokoi K; Nishizawa N; Washio M; Ushiku H; Katoh H; Kosaka Y; Mieno H; Hosoda K; Watanabe M; Katada C; Hiki N; Yamashita K
Ann Surg Oncol; 2019 Dec; 26(13):4814-4825. PubMed ID: 31529309
[TBL] [Abstract][Full Text] [Related]
10. Clinical and translational advances in esophageal squamous cell carcinoma.
Reichenbach ZW; Murray MG; Saxena R; Farkas D; Karassik EG; Klochkova A; Patel K; Tice C; Hall TM; Gang J; Parkman HP; Ward SJ; Tétreault MP; Whelan KA
Adv Cancer Res; 2019; 144():95-135. PubMed ID: 31349905
[TBL] [Abstract][Full Text] [Related]
11. IGF2 induces CD133 expression in esophageal cancer cells to promote cancer stemness.
Xu WW; Li B; Zhao JF; Yang JG; Li JQ; Tsao SW; He QY; Cheung ALM
Cancer Lett; 2018 Jul; 425():88-100. PubMed ID: 29604392
[TBL] [Abstract][Full Text] [Related]
12. Single‑cell intratumoral stemness analysis reveals the involvement of cell cycle and DNA damage repair in two different types of esophageal cancer.
Wu H; Li Y; Hou Q; Zhou R; Li Z; Wu S; Yu J; Jiang M
Oncol Rep; 2019 Jun; 41(6):3201-3208. PubMed ID: 31002369
[TBL] [Abstract][Full Text] [Related]
13. TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma.
Pham QT; Oue N; Sekino Y; Yamamoto Y; Shigematsu Y; Sakamoto N; Sentani K; Uraoka N; Yasui W
Oncology; 2018; 95(5):297-308. PubMed ID: 30134247
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma.
Yu J; Wu X; Huang K; Zhu M; Zhang X; Zhang Y; Chen S; Xu X; Zhang Q
Mol Med Rep; 2019 Jun; 19(6):5309-5320. PubMed ID: 31059058
[TBL] [Abstract][Full Text] [Related]
15. DNA N6-methyladenine increased in human esophageal squamous cell carcinoma.
Chen L; Zhang M; Guo M
Discov Med; 2020; 29(157):85-90. PubMed ID: 33002404
[TBL] [Abstract][Full Text] [Related]
16. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
[TBL] [Abstract][Full Text] [Related]
17. Managing Squamous Cell Esophageal Cancer.
Batra R; Malhotra GK; Singh S; Are C
Surg Clin North Am; 2019 Jun; 99(3):529-541. PubMed ID: 31047040
[TBL] [Abstract][Full Text] [Related]
18. Identification of esophageal cancer pathway deviation and construction of a diagnosis model using three kernel genes.
Xue W; Fan Z; Li L; Yan D; Shen Z; Zhai Y; Kan Q; Zhao J
J Cell Physiol; 2019 Aug; 234(10):18098-18110. PubMed ID: 30835828
[TBL] [Abstract][Full Text] [Related]
19. Expression Level of miR-34a in Tumor Tissue from Patients with Esophageal Squamous Cell Carcinoma.
Asadi M; Shanehbandi D; Mohammadpour H; Hashemzadeh S; Sepehri B
J Gastrointest Cancer; 2019 Jun; 50(2):304-307. PubMed ID: 29453761
[TBL] [Abstract][Full Text] [Related]
20. B7H4 is associated with stemness and cancer progression in esophageal squamous cell carcinoma.
Piao L; Yang Z; Jin J; Ni W; Qi W; Xuan Y
Hum Pathol; 2018 Oct; 80():152-162. PubMed ID: 29885401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
